Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sitagliptin (25mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
1x7
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Istalab 25 Tablet containing Sitagliptin is used for the management of type 2 diabetes mellitus. It helps in controlling blood sugar levels and improving overall glycemic control.
Sitagliptin works as a DPP-4 inhibitor, which increases insulin release after meals and reduces glucose production, helping maintain stable blood sugar levels.
The tablet is widely prescribed in diabetic care for long-term management, often used as part of combination therapy, leading to consistent demand and repeat usage.
With increasing prevalence of diabetes and growing awareness of glucose control management, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and wide acceptance in endocrinology practice make it a reliable product for consistent sales and growth in the anti-diabetic segment.
Some patients may experience headache, upper respiratory tract infections, nasal congestion, nausea, or mild gastrointestinal discomfort. Rarely, pancreatitis, joint pain, or severe allergic reactions may occur and require medical attention.
Istalab 25 Tablet is indicated for the management of type 2 diabetes mellitus, either alone or in combination with other antidiabetic agents. It helps reduce fasting and postprandial blood glucose levels, improve insulin response, and support long-term glycemic control.
This medicine should be used under medical supervision along with diet and exercise control. Regular monitoring of blood glucose levels is recommended. Patients with pancreatic or kidney issues should use it cautiously.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Dapagliflozin 5mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Sitagliptin Phosphate I.P. 100mg Tablets
Composition : Sitagliptin Phosphate I.P. 50mg + Metformin HCL I.P. 1000mg Tablets
Composition : Sitagliptin Phosphate I.P. 50mg + Metformin HCL I.P. 500mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Istalab 25 Tablet, containing Sitagliptin 25mg, has strong demand in the diabetes care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic and chronic care portfolios.
Medical distributors and agencies can benefit from the growing and long-term demand for DPP-4 inhibitors used in the management of type 2 diabetes mellitus, especially as part of combination or dose-adjusted therapy. Istalab 25 Tablet helps strengthen a comprehensive diabetic care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Istalab 25 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady chronic prescription demand, long-term market stability, reliable supply chain support, and professional assistance when partnering for Istalab 25 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Istalab 25 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.